U.S. Markets
Gilead (GILD) nears up to USD 2bln deal for autoimmune biotech Ouro Medicines, according to FT
Related stocks
1 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
